FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134776089> ?p ?o ?g. }

• W3134776089 endingPage "178" @default.
• W3134776089 startingPage "171" @default.
• W3134776089 abstract "Lenvatinib is one of the first-line drugs for patients with advanced hepatocellular carcinoma (HCC) and widely used around the world. However, the mechanisms underlying resistance to lenvatinib remain unclear. In this study, we conducted characteristic analyses of lenvatinib-resistant HCC cells. Lenvatinib-resistant HCC cell lines were established by exposure to serially escalated doses of lenvatinib over 2 months. The biological characteristics of these cells were examined by in vitro assays. To investigate the cytokine profile of lenvatinib-resistant HCC cells, the supernatant derived from lenvatinib-resistant Huh7 cells was subjected to nitrocellulose membrane-based sandwich immunoassay. Both activation of the MAPK/MEK/ERK signaling pathway and upregulation of epithelial mesenchymal transition markers were observed in lenvatinib-resistant cells. Concordant with these findings, proliferation and invasion abilities were enhanced in these cells compared with control cells. Screening of a cytokine array spotted with 105 different antibodies to human cytokines enabled us to identify 16 upregulated cytokines in lenvatinib-resistant cells. Among them, 3 angiogenic cytokines: vascular endothelial growth factor (VEGF), platelet-derived growth factor-AA (PDGF-AA), and angiogenin, were increased significantly. Conditioned medium from lenvatinib-resistant cells accelerated tube formation of human umbilical vein cells. In conclusion, lenvatinib-resistant HCC cells were characterized by enhanced proliferation and invasion abilities. These findings might contribute to the establishment of new combination therapies with lenvatinib." @default.
• W3134776089 created "2021-03-15" @default.
• W3134776089 creator A5001002762 @default.
• W3134776089 creator A5001204429 @default.
• W3134776089 creator A5004878185 @default.
• W3134776089 creator A5011517986 @default.
• W3134776089 creator A5016770705 @default.
• W3134776089 creator A5016927438 @default.
• W3134776089 creator A5022431851 @default.
• W3134776089 creator A5030300141 @default.
• W3134776089 creator A5031528034 @default.
• W3134776089 creator A5032653442 @default.
• W3134776089 creator A5035908413 @default.
• W3134776089 creator A5038679040 @default.
• W3134776089 creator A5041139736 @default.
• W3134776089 creator A5044731371 @default.
• W3134776089 creator A5047431198 @default.
• W3134776089 creator A5048967405 @default.
• W3134776089 creator A5071892047 @default.
• W3134776089 creator A5079731833 @default.
• W3134776089 creator A5082589527 @default.
• W3134776089 creator A5082785148 @default.
• W3134776089 creator A5086641988 @default.
• W3134776089 creator A5087746251 @default.
• W3134776089 creator A5090599179 @default.
• W3134776089 creator A5070637097 @default.
• W3134776089 date "2021-04-01" @default.
• W3134776089 modified "2023-10-16" @default.
• W3134776089 title "Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells" @default.
• W3134776089 cites W1971837077 @default.
• W3134776089 cites W1994193851 @default.
• W3134776089 cites W2020903165 @default.
• W3134776089 cites W2038569449 @default.
• W3134776089 cites W2038625523 @default.
• W3134776089 cites W2051165598 @default.
• W3134776089 cites W2112064600 @default.
• W3134776089 cites W2112796039 @default.
• W3134776089 cites W2136269710 @default.
• W3134776089 cites W2141358606 @default.
• W3134776089 cites W2164291943 @default.
• W3134776089 cites W2165667751 @default.
• W3134776089 cites W2169302611 @default.
• W3134776089 cites W2264801869 @default.
• W3134776089 cites W2277004004 @default.
• W3134776089 cites W2346310518 @default.
• W3134776089 cites W2403104238 @default.
• W3134776089 cites W2529646902 @default.
• W3134776089 cites W2618584271 @default.
• W3134776089 cites W2625856057 @default.
• W3134776089 cites W2783337717 @default.
• W3134776089 cites W2787358630 @default.
• W3134776089 cites W2796067155 @default.
• W3134776089 cites W2800499107 @default.
• W3134776089 cites W2883781711 @default.
• W3134776089 cites W2892757136 @default.
• W3134776089 cites W2906272152 @default.
• W3134776089 cites W2915074980 @default.
• W3134776089 cites W2929062492 @default.
• W3134776089 cites W2949660400 @default.
• W3134776089 cites W2963303825 @default.
• W3134776089 cites W2964450000 @default.
• W3134776089 cites W2988773550 @default.
• W3134776089 cites W3014283231 @default.
• W3134776089 cites W3025022288 @default.
• W3134776089 cites W3042689819 @default.
• W3134776089 doi "https://doi.org/10.1016/j.bbrc.2021.02.097" @default.
• W3134776089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33676186" @default.
• W3134776089 hasPublicationYear "2021" @default.
• W3134776089 type Work @default.
• W3134776089 sameAs 3134776089 @default.
• W3134776089 citedByCount "9" @default.
• W3134776089 countsByYear W31347760892021 @default.
• W3134776089 countsByYear W31347760892022 @default.
• W3134776089 countsByYear W31347760892023 @default.
• W3134776089 crossrefType "journal-article" @default.
• W3134776089 hasAuthorship W3134776089A5001002762 @default.
• W3134776089 hasAuthorship W3134776089A5001204429 @default.
• W3134776089 hasAuthorship W3134776089A5004878185 @default.
• W3134776089 hasAuthorship W3134776089A5011517986 @default.
• W3134776089 hasAuthorship W3134776089A5016770705 @default.
• W3134776089 hasAuthorship W3134776089A5016927438 @default.
• W3134776089 hasAuthorship W3134776089A5022431851 @default.
• W3134776089 hasAuthorship W3134776089A5030300141 @default.
• W3134776089 hasAuthorship W3134776089A5031528034 @default.
• W3134776089 hasAuthorship W3134776089A5032653442 @default.
• W3134776089 hasAuthorship W3134776089A5035908413 @default.
• W3134776089 hasAuthorship W3134776089A5038679040 @default.
• W3134776089 hasAuthorship W3134776089A5041139736 @default.
• W3134776089 hasAuthorship W3134776089A5044731371 @default.
• W3134776089 hasAuthorship W3134776089A5047431198 @default.
• W3134776089 hasAuthorship W3134776089A5048967405 @default.
• W3134776089 hasAuthorship W3134776089A5070637097 @default.
• W3134776089 hasAuthorship W3134776089A5071892047 @default.
• W3134776089 hasAuthorship W3134776089A5079731833 @default.
• W3134776089 hasAuthorship W3134776089A5082589527 @default.
• W3134776089 hasAuthorship W3134776089A5082785148 @default.
• W3134776089 hasAuthorship W3134776089A5086641988 @default.
• W3134776089 hasAuthorship W3134776089A5087746251 @default.

• next